methylnitronitrosoguanidine has been researched along with Thyroid-Neoplasms* in 3 studies
3 other study(ies) available for methylnitronitrosoguanidine and Thyroid-Neoplasms
Article | Year |
---|---|
Promoting effects of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone on rat glandular stomach carcinogenesis initiated with N-methyl-N'-nitro-N-nitrosoguanidine.
The modifying effects of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), a mutagenic by-product in chlorinated water, on the development of glandular stomach cancers were investigated in Wistar rats. A total of 120 males, 6 weeks of age, were divided into six groups. After initiation with 100 ppm N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) solution and 5% NaCl diet for 8 weeks, 30 rats each in groups 1-3 were given MX in the drinking water at concentrations of 30, 10, or 0 ppm for the following 57 weeks. Ten animals each in groups 4-6 were administered the MX without prior carcinogen exposure. There were no statistical significant differences in final body weights between the groups. The incidences and multiplicities of adenocarcinomas in the glandular stomachs were significantly higher (P < 0.05) in the initiated 30 ppm MX group than those in the MNNG/NaCl group. The incidences of atypical hyperplasias in the glandular stomachs were also significantly increased (P < 0.05 or 0.01) by the MX treatments. With their multiplicity, the effects were clearly dose dependent. Interestingly, the 30 ppm MX alone itself induced atypical hyperplasias in the pylorus, although the incidences and severity were low. Moreover, MX showed a tendency to enhance the development of intrahepatic cholangiocellular tumors and thyroid follicular cell tumors in the MNNG-treated animals. The results of the present study thus indicate that MX exerts promoting effects when given during the postinitiation phase of two-stage glandular stomach carcinogenesis in rats. Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Adenoma, Bile Duct; Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Body Weight; Carcinogens; Cholangiocarcinoma; Cocarcinogenesis; Fibrosis; Furans; Hyperplasia; Male; Methylnitronitrosoguanidine; Mutagens; Organ Size; Precancerous Conditions; Pylorus; Rats; Rats, Wistar; Stomach; Stomach Diseases; Stomach Neoplasms; Thyroid Neoplasms; Water Pollutants, Chemical | 1999 |
High frequency of thyroid tumor induction by N-methyl-N'-nitro-N-nitrosoguanidine in the hermaphroditic fish Rivulus marmoratus.
In the self-fertilizing hermaphroditic fish, Rivulus marmoratus, the susceptibility to tumor induction by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) was evaluated. Seven-day-old fish larvae were exposed for 2 h to MNNG at concentrations ranging from 5 to 25 ppm in a static water bath. The exposed fish were observed at 2 and 4 months after carcinogen treatment to assess tumor development. Within 4 months after 25 ppm MNNG exposure, nearly all fish developed thyroid tumors. The tumor incidences were dose- and time-dependent, and the latent period of tumor induction was less than 2 months. Most induced neoplasms were papillary carcinomas similar histologically to those of rodents and humans, and the tumors were serially transplantable to other fish of the same species. These results demonstrate that rivulus could be useful as a model of thyroid carcinogenesis. Topics: Animals; Dose-Response Relationship, Drug; Fishes; Methylnitronitrosoguanidine; Neoplasm Transplantation; Thyroid Neoplasms | 1993 |
Spontaneous and induced chromosome damage in lymphocytes of medullary thyroid carcinoma patients and their family members.
Detailed chromosome analysis failed to reveal any evidence for spontaneous chromosome instability in lymphocytes from patients with multiple endocrine neoplasia, type 2 (MEN-2), whereas, with one exception, lymphocytes from MEN-2 patients were significantly more sensitive to chromosome damage by bleomycin and, to a lesser extent, MNNG than those from controls. The exceptional case suggests possible genetic heterogeneity in MEN-2. Topics: Adult; Bleomycin; Carcinoma; Chromosome Aberrations; Humans; Lymphocytes; Methylnitronitrosoguanidine; Multiple Endocrine Neoplasia; Thyroid Neoplasms | 1988 |